Shomi S Bhattacharya Selected Research

RNA Splicing Factors

9/2017	Gene of the month: PRPF31.
5/2010	Prognosis for splicing factor PRPF8 retinitis pigmentosa, novel mutations and correlation between human and yeast phenotypes.
12/2009	Study of gene-targeted mouse models of splicing factor gene Prpf31 implicated in human autosomal dominant retinitis pigmentosa (RP).
4/2008	Disease mechanism for retinitis pigmentosa (RP11) caused by missense mutations in the splicing factor gene PRPF31.
7/2007	Mutations in splicing factor PRPF3, causing retinal degeneration, form detrimental aggregates in photoreceptor cells.
3/2007	Mutations in the gene coding for the pre-mRNA splicing factor, PRPF31, in patients with autosomal dominant retinitis pigmentosa.
3/2006	A study of the nuclear trafficking of the splicing factor protein PRPF31 linked to autosomal dominant retinitis pigmentosa (ADRP).
12/2002	Disease mechanism for retinitis pigmentosa (RP11) caused by mutations in the splicing factor gene PRPF31.
1/2002	Mutations in HPRP3, a third member of pre-mRNA splicing factor genes, implicated in autosomal dominant retinitis pigmentosa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shomi S Bhattacharya Research Topics

Disease

24	Retinitis Pigmentosa (Pigmentary Retinopathy) 11/2016 - 01/2002
7	Retinal Dystrophies 01/2016 - 10/2004
7	Cone-Rod Dystrophies 01/2012 - 01/2004
6	Retinal Degeneration 10/2014 - 12/2006
5	Leber Congenital Amaurosis 08/2010 - 07/2004
4	Cataract (Cataracts) 01/2019 - 03/2009
4	Macular Degeneration (Age-Related Maculopathy) 11/2014 - 07/2006
3	congenital stationary Night blindness 12/2013 - 02/2012
3	Blindness (Hysterical Blindness) 05/2012 - 10/2004
3	Atrophy 01/2011 - 07/2004
3	Hereditary Corneal Dystrophies 01/2008 - 02/2002
2	Ganglion Cysts (Ganglion) 01/2016 - 01/2014
2	Rare Diseases (Rare Disease) 01/2016 - 11/2014
2	Vitelliform Macular Dystrophy 01/2011 - 10/2004
2	Leukemia 11/2007 - 12/2006
2	Glaucoma 01/2007 - 06/2002
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016
1	Cardiomyopathies (Cardiomyopathy) 01/2016
1	Gliosis 02/2014
1	Alzheimer Disease (Alzheimer's Disease) 01/2014
1	Retinal Diseases 01/2014
1	Dementia (Dementias) 01/2014
1	Hypoxia (Hypoxemia) 05/2012
1	Vision Disorders (Hemeralopia) 02/2012
1	Telangiectasis (Telangiectasia) 02/2012
1	Myopia 01/2012
1	Refractive Errors (Refractive Error) 01/2012
1	Cerebellar Ataxia (Dysmetria) 04/2011
1	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 01/2011
1	Giant Axonal Neuropathy 06/2009
1	Ciliopathies 06/2009
1	Early Onset Severe Retinal Dystrophy 05/2008
1	Cone Dystrophy 01/2004

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2002
15	Retinaldehyde (Retinal)IBA 01/2016 - 07/2004
9	RNA Splicing FactorsIBA 09/2017 - 01/2002
4	RNA Precursors (Precursor, mRNA)IBA 10/2014 - 01/2002
3	Messenger RNA (mRNA)IBA 01/2014 - 10/2003
3	Rhodopsin (Visual Purple)IBA 01/2012 - 12/2006
2	NucleotidesIBA 01/2019 - 12/2006
2	c-Mer Tyrosine KinaseIBA 08/2015 - 03/2010
2	BestrophinsIBA 07/2013 - 10/2004
2	Arginine (L-Arginine)FDA Link 03/2011 - 01/2004
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 03/2011 - 11/2007
2	Serine (L-Serine)FDA Link 03/2011 - 01/2004
2	SulfotransferasesIBA 01/2005 - 02/2002
2	CarbohydratesIBA 01/2005 - 02/2002
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2020
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2019
1	polyarginineIBA 11/2016
1	UbiquitinIBA 01/2016
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2016
1	Asparaginase (Elspar)FDA Link 01/2016
1	Glycoproteins (Glycoprotein)IBA 11/2014
1	Fibrillin-2IBA 11/2014
1	ElastinIBA 11/2014
1	TubulinIBA 05/2014
1	Chondroitin Sulfate ProteoglycansIBA 02/2014
1	Amyloid (Amyloid Fibrils)IBA 01/2014
1	RNA (Ribonucleic Acid)IBA 01/2014
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2013
1	TungstenIBA 12/2013
1	Guanylate Cyclase-Activating ProteinsIBA 01/2013
1	SuspensionsIBA 05/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2012
1	Complement Factor H (Factor H)IBA 02/2012
1	Glucose (Dextrose)FDA LinkGeneric 01/2012
1	Nuclear Proteins (Protein, Nuclear)IBA 03/2011
1	Amino Acids FDA Link 01/2011
1	Retinal Pigments (Pigments, Visual)IBA 01/2011
1	acceleratory factor from growth hormone (AcG)IBA 01/2011
1	Retinal DehydrogenaseIBA 01/2011
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2010
1	DNA (Deoxyribonucleic Acid)IBA 03/2010
1	GTP Phosphohydrolases (GTPases)IBA 06/2009
1	EphA2 ReceptorIBA 05/2009
1	EphrinsIBA 05/2009
1	VimentinIBA 03/2009
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2008
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2007
1	ElementsIBA 07/2007
1	Cytochrome P-450 CYP1B1IBA 01/2007
1	trabecular meshwork-induced glucocorticoid response proteinIBA 01/2007
1	fibulinIBA 07/2006
1	Carbonic Anhydrase IVIBA 01/2005
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2005
1	SymportersIBA 01/2005
1	HydrocarbonsIBA 10/2004
1	aryl hydrocarbon receptor-interacting proteinIBA 07/2004
1	Codon (Codons)IBA 01/2004
1	Mutant Proteins (Protein, Mutant)IBA 01/2004
1	Cysteine (L-Cysteine)FDA Link 01/2004
1	Histidine (L-Histidine)FDA Link 01/2004
1	ribosomal protein 29 (RP29)IBA 11/2002

Therapy/Procedure

3	Therapeutics 05/2012 - 03/2009
2	Transplantation 02/2014 - 04/2011
1	Cell Transplantation 02/2014